PTC THERAPEUTICS, INC. — Director's Dealing 2021

Feb 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2021-02-01

Reporting Person: Peltz Stuart Walter (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-01	Common Stock	S	1968	$56.956	Disposed	80315	Direct
2021-02-01	Common Stock	S	283	$56.956	Disposed	15081	Indirect

Footnotes

F1: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 8,250 RSUs from a January 29, 2020 grant of 33,000 RSUs.

F2: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 1,213 RSUs from a January 29, 2020 grant of 4,855 RSUs.